3M syndrome (myasthenia, myositis, myocarditis) related to nivolumab treatment

F. Rouby, E. Polard, T. Pietri, D. Laugier,J. Micallef

FUNDAMENTAL & CLINICAL PHARMACOLOGY(2022)

引用 0|浏览1
暂无评分
关键词
3M syndrome, nivolumab, immune checkpoint inhibitor, immune-related adverse events
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要